Journal of Internal Medicine

Journal of Internal Medicine Journal of Internal Medicine is a peer-reviewed medical journal with Impact Factor 7.6

JIM – Journal of Internal Medicine is an international peer-reviewed scientific journal in continuous publication since 1863. JIM publishes original work in clinical science from bench to bedside covering a broad field of internal medicine and its subspecialties. JIM features original articles, reviews, brief reports and research letters.

Welcome to read the Editor´s Choice in July!➡️  Contrast-enhanced CT—Nephrotoxic or not?➡️  A critical review of propens...
01/07/2026

Welcome to read the Editor´s Choice in July!

➡️ Contrast-enhanced CT—Nephrotoxic or not?
➡️ A critical review of propensity-score-adjusted studies.

🔗 doi.org/10.1111/joim.70095

👉 Also, read the July issue: onlinelibrary.wiley.com/toc/13652796...

The July issue is now online!👉 Read our latest articles: onlinelibrary.wiley.com/toc/13652796/2026/300/1
22/06/2026

The July issue is now online!

👉 Read our latest articles: onlinelibrary.wiley.com/toc/13652796/2026/300/1

New Letter to the editor to read! Authors’ reply: Myasthenia gravis following the initiation of statin therapy.🔗 doi.org...
16/06/2026

New Letter to the editor to read! Authors’ reply: Myasthenia gravis following the initiation of statin therapy.

🔗 doi.org/10.1111/joim.70123

👉 Also, read the articles it is commenting on! doi.org/10.1111/joim.70072, doi.org/10.1111/joim.70122

New review to read! The changing epidemiology of human type 2 diabetes–associated atherosclerosis.➡️ Pathophysiological ...
15/06/2026

New review to read! The changing epidemiology of human type 2 diabetes–associated atherosclerosis.

➡️ Pathophysiological mechanisms and emerging treatment possibilities.

🔗 doi.org/10.1111/joim.70118

Advances towards an mRNA vaccine to HIV-1: "mRNA is likely to be critical enabler for clinical testing and development o...
15/06/2026

Advances towards an mRNA vaccine to HIV-1: "mRNA is likely to be critical enabler for clinical testing and development of an HIV vaccine".

➡️ 20th Key symposium! What have we learnt from the mRNA vaccine platform? Stockholm, Sweden. June 15-17 2026.

👉 kva.se/key2026

Continuing! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?➡️ At The Royal Swedish Academy o...
15/06/2026

Continuing! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?

➡️ At The Royal Swedish Academy of Sciences, Stockholm, Sweden. June 15-17 2026.

👉 Programme: kva.se/key2026

Starting now! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?➡️ At The Royal Swedish Academy...
15/06/2026

Starting now! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?

➡️ At The Royal Swedish Academy of Sciences, Stockholm, Sweden. June 15-17 2026.

👉 Programme: kva.se/key2026

Today! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?➡️ At The Royal Swedish Academy of Sci...
15/06/2026

Today! The 20th Key symposium! What have we learnt from the mRNA vaccine platform?

➡️ At The Royal Swedish Academy of Sciences, Stockholm, Sweden. June 15-17 2026.

👉 Programme: kva.se/key2026

New Letter to the Editor to read! Regarding: Myasthenia gravis following the initiation of statin therapy.🔗 doi.org/10.1...
10/06/2026

New Letter to the Editor to read! Regarding: Myasthenia gravis following the initiation of statin therapy.

🔗 doi.org/10.1111/joim.70122

👉 Also, read the original article it is commenting on! doi.org/10.1111/joim.70072

New review to read from Karolinska Institutet! Brain pathology in relation to somatic diseases: Exploring the body–brain...
09/06/2026

New review to read from Karolinska Institutet! Brain pathology in relation to somatic diseases: Exploring the body–brain crosstalk.

➡️ From the symposium: Beyond amyloid and tau: The importance of co-pathologies in Alzheimer's disease.

🔗 doi.org/10.1111/joim.70119

Adress

Tomtebodavägen 9
Solna
17165

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när Journal of Internal Medicine postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Genvägar

Dela